These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 234291
1. Immunotherapy of melanoma with BCG: two fatalities following intralesional injection. McKhann CF, Hendrickson CG, Spitler LE, Gunnarsson A, Banerjee D, Nelson WR. Cancer; 1975 Feb; 35(2):514-20. PubMed ID: 234291 [Abstract] [Full Text] [Related]
2. Treatment of malignant melanoma by intratumoral injection of BCG. Pinsky CM, Hirshaut Y, Oettgen HF. Natl Cancer Inst Monogr; 1973 Dec; 39():225-8. PubMed ID: 4595322 [No Abstract] [Full Text] [Related]
3. Anaphylactic reaction to intralesional B.C.G. Proctor JW, Zidar B, Pomerantz M, Yamamura Y, Eng CP, Woodside D. Lancet; 1978 Jul 15; 2(8081):162. PubMed ID: 78369 [No Abstract] [Full Text] [Related]
4. Severe complications of intralesional BCG therapy in an unsensitized patient. Case report and clinical implications. Felix EL, Jessup JM, Cohen MH. Arch Surg; 1978 Jul 15; 113(7):893-6. PubMed ID: 678104 [Abstract] [Full Text] [Related]
5. Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases. Mastrangelo MJ, Bellet RE, Berkelhammer J, Clark WH. Cancer; 1975 Oct 15; 36(4):1305-8. PubMed ID: 1175129 [Abstract] [Full Text] [Related]
6. Immunotherapy of melanoma with intralesional BCG. Bornstein RS, Mastrangelo MJ, Sulit H, Chee D, Yarbro JW, Prehn LM, Prehn RT. Natl Cancer Inst Monogr; 1973 Dec 15; 39():213-20. PubMed ID: 4595320 [No Abstract] [Full Text] [Related]
7. A clinical trial of BCG immunotherapy as an adjunct to surgery in the treatment of primary malignant melanoma. O'Connor TP, Labandter HP, Hiles RW, Bodenham DC. Br J Plast Surg; 1978 Oct 15; 31(4):317-22. PubMed ID: 361132 [Abstract] [Full Text] [Related]
8. Fatal disseminated bacillus Calmette-Guerin infection and arrested growth of cutaneous malignant melanoma following intralesional immunotherapy. de la Monte SM, Hutchins GM. Am J Dermatopathol; 1986 Aug 15; 8(4):331-5. PubMed ID: 3532854 [Abstract] [Full Text] [Related]
18. [Use of immunotherapy in the treatment of malignant melanoma of the skin]. Kristensen E. Ugeskr Laeger; 1976 Feb 16; 138(8):468-73. PubMed ID: 1258215 [No Abstract] [Full Text] [Related]